Brief: Esprinet Signs Deal To Buy Residual 15% Of Celly

Esprinet SpA

28/10/2020 14:24

Oct 28 (Reuters) - Esprinet SpA  PRT.MI :
    * SIGNS DEAL TO BUY RESIDUAL 15% OF CELLY
    * VALUE OF TRANSACTION IS EUR 1.25 MILLION
    * FROM NOVEMBER 1 STEFANO BONFANTI CURRENT PRESIDENT AND CEO
OF
CELLY ASSUMES POSITION OF HEAD OF SALES AND MARKETING OF
ESPRINET'S CELLY DIVISION

Source text: bit.ly/3mt8VIW
Further company coverage:  PRT.MI 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))